News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy
Yüksel Ürün/X
Mar 27, 2025, 07:15

Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article by Amar U Kishan, et al. on X:

“HYDRA Study (MARCAP):

Moderately hypofractionated radiotherapy (MHFRT) is as effective as conventionally fractionated radiotherapy (CFRT).
Dose-escalated MHFRT increases bowel toxicity without survival benefit.”

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

Author: Amar U Kishan,et al.

Yüksel Ürün: Moderately hypofractionated radiotherapy is as effective as conventionally fractionated radiotherapy

More posts featuring Yüksel Ürün.

 

Amar U. Kishan cancer Cancer research MHFRT moderately hypofractionated radiotherapy OncoDaily Oncology prostate cancer Yüksel Ürün
Special Coverage
Blog
Mar 30, 2025, 16:09
Hedley Lewis: No Family Should Face Childhood Cancer and Life-Threatening Blood Disorders Alone
Blog
Mar 30, 2025, 16:06
Anant Madabhushi: New Publication on AI-Driven Virtual Staining for Tumor-Associated Macrophages
Blog
Mar 30, 2025, 16:03
Research drives progress, and advocacy fuels change - Fight Colorectal Cancer
Blog
Mar 30, 2025, 15:52
St. Baldrick's Foundation - Honoring our heroes on National Doctors' Day
Blog
Mar 30, 2025, 15:48
Our experts are in Orlando for NCCN2025 - Roswell Park
Blog
Mar 30, 2025, 15:42
Peter Pisters: Honoring MD Anderson Cancer Center's Physicians on Doctors' Day for their commitment
Blog
Mar 30, 2025, 15:41
New NCI Funding Opportunity to New NCI Funding Opportunity to Address Cancer-Related Financial Hardship to Improve Patient Outcomes
Blog
Mar 30, 2025, 15:37
How PROs and CROs provide different but equally vital information - ESMO
Blog
Mar 30, 2025, 15:24
EORTC is Looking For a Medical Liaison Officer in Brussels
Blog
Mar 30, 2025, 15:14
Leandro Jonata Carvalho: Honored to participate in the 2025 LACOG-GBECAM Brazilian Breast Cancer Conference
Science
Mar 30, 2025, 15:09
Katsuaki Maehara: Genome doubling identified as a key factor in resistance for EGFRm lung cancer
Blog
Mar 30, 2025, 15:00
Jae Won Joh: Bill Gates Predicts AI Will Replace Doctors – But Who Takes on the Liability?